SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-012629
Filing Date
2022-05-05
Accepted
2022-05-05 16:05:57
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20220331.htm   iXBRL 10-Q 1141731
2 EX-31.1 sgmo-20220331xex311.htm EX-31.1 10154
3 EX-31.2 sgmo-20220331xex312.htm EX-31.2 10269
4 EX-32.1 sgmo-20220331xex321.htm EX-32.1 7218
  Complete submission text file 0001628280-22-012629.txt   5496098

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20220331.xsd EX-101.SCH 40759
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20220331_cal.xml EX-101.CAL 65582
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20220331_def.xml EX-101.DEF 204859
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20220331_lab.xml EX-101.LAB 427108
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20220331_pre.xml EX-101.PRE 298426
45 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20220331_htm.xml XML 974375
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 22896157
SIC: 2836 Biological Products, (No Diagnostic Substances)